Listed since August 2026
The DHQ RWP PANEL Molecular Concerns Lab is a laboratory facility listed in the DHQ and Raja Bazar area of Rawalpindi, Pakistan. The facility is associated with laboratory diagnostic services and molecular testing and is listed at Dickson Chemist, DHQ, Raja Bazar, Rawalpindi.
The laboratory operates in the Rawalpindi healthcare environment and provides diagnostic laboratory support for patients requiring clinical investigations. Molecular laboratory services are particularly important for the detection and investigation of infectious diseases and other conditions where specialized laboratory techniques are required.
The Molecular Concerns Lab has also been documented as a COVID-19 PCR testing facility in Rawalpindi. A Punjab Healthcare Commission list of approved COVID laboratories identifies The Molecular Concerns Lab at F-833/3, opposite Gate No. 2, Holy Family Hospital, Rawalpindi, as a private PCR facility.
Available laboratory-report evidence associated with The Molecular Concerns Lab shows testing in areas including clinical biochemistry, hematology, serology and molecular biology. Reported investigations include liver function testing, renal function testing, lipid profile, complete blood picture, hepatitis screening and other infectious-disease related investigations.
The laboratory has also been associated with professional laboratory management and molecular diagnostic work in Rawalpindi. Available professional documentation describes work involving COVID-19 RT-PCR diagnostics and laboratory operations at The Molecular Concerns Lab.
Patients should confirm the current branch location, available investigations, sample requirements, fees and reporting times before visiting, as laboratory services and branch arrangements can change.
For the DHQ Raja Bazar listing, the currently available contact number is 051-8742432. The facility is listed at Dickson Chemist, DHQ, Raja Bazar, Rawalpindi.
The Molecular Concerns Lab has experience in molecular diagnostic services, including PCR-based testing. The laboratory was listed by the Punjab Healthcare Commission as a private COVID-19 PCR facility in Rawalpindi.
COVID-19 RT-PCR testing has been associated with The Molecular Concerns Lab. Professional documentation also describes laboratory work involving COVID-19 RT-PCR diagnostics at the facility.
The laboratory's documented reports include hematology investigations such as a Complete Blood Picture. A blood count can provide information about red blood cells, white blood cells, hemoglobin, hematocrit and platelets and may be requested as part of routine diagnostic assessment.
Complete Blood Picture testing is documented in laboratory reports associated with The Molecular Concerns Lab. The investigation evaluates major blood-cell parameters and is commonly used for general health assessment and evaluation of various clinical conditions.
Clinical biochemistry investigations are also documented in available laboratory reports. These investigations can help evaluate biochemical markers related to organs and general metabolic health.
Liver Function Tests are documented in available reports from The Molecular Concerns Lab. These investigations may include biochemical markers used to assess liver-related function and support clinical evaluation.
Renal Function Tests are also documented in laboratory reporting associated with the facility. These investigations are used to assess markers related to kidney function, including parameters such as urea and creatinine.
Lipid Profile testing is documented in available laboratory reports. It may include measurements such as total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol for assessment of blood lipid levels.
Available reports document hepatitis-related screening, including Hepatitis B surface antigen and Hepatitis C antibody testing. Positive or borderline screening results may require confirmatory testing according to the applicable laboratory protocol.
The laboratory's documented reports include serological investigations used to detect antibodies or antigens associated with infectious diseases. Examples in available reports include hepatitis screening and typhoid-related antibody testing.
Typhoid-related serological testing, including Typhidot IgG and IgM, is documented in available laboratory reports. Interpretation and confirmation should always be considered alongside clinical assessment and appropriate confirmatory testing.
The laboratory's molecular and serological capabilities support diagnostic investigation of infectious diseases. The exact current range of infectious-disease tests should be confirmed with the laboratory before sample submission.
Sample collection is an essential part of diagnostic testing. Depending on the investigation, the laboratory may process blood and other clinical specimens according to the requirements of the requested test.
Laboratory investigations are followed by preparation of diagnostic reports containing the patient's test results and reference information. Patients should confirm report collection or delivery options and expected turnaround time when submitting samples.
The laboratory provides diagnostic support through hematology, biochemistry, serology and molecular testing. The exact availability of individual investigations, charges and turnaround times may vary and should be confirmed directly with the facility.
Patients should bring the relevant laboratory prescription or test request when required. Some investigations may require fasting, special sample collection or other preparation. It is advisable to contact the laboratory before visiting to confirm the current test menu and preparation requirements.